An ongoing trial where the chemotherapy drug is injected directly into the abdominal cavity of patients with a particular type of stomach cancer has
allowed more than two-thirds of them to live beyond a year.Please subscribe or log in to continue reading the full article. Learn more about ST PREMIUM.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: